Exagen Inc. (XGN) Dividend History

Company News

• Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors

  If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Exagen (XGN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

  Zacks Investment Research
• Time to Play 5 Top-Ranked Stocks With Rising P/E?

  Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA Sciences (APDN).

  Zacks Investment Research

  Featured Companies: AMC APDN HCAT YOU
• Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

  Exagen (XGN) delivered earnings and revenue surprises of 52.50% and 9.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: MDT
• Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

  Quanterix (QTRX) delivered earnings and revenue surprises of 21.21% and 1.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: QTRX
• Exagen to Announce First Quarter 2024 Results on May 13, 2024

  CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on Monday, May 13, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 AM ET (5:30 AM PT).

  GlobeNewswire Inc.